Drug Search Results
More Filters [+]

Daidzein

Alternative Names: daidzein
Latest Update: 2024-05-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: TNF Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: India

Approved Indications: None

Known Adverse Events: None

Company: Third Military Medical University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Daidzein

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Prostate Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2000034019

N/A

Recruiting

Prostate Cancer

2024-06-23

KLKN 14-04-2014

N/A

Completed

Osteoporosis|Bone Diseases, Metabolic

2016-10-01

4P-07-3

P2

Completed

Prostate Cancer

2014-07-08

ISOII

N/A

Completed

Menopause

2012-09-01

Recent News Events